QuickView for tnfrsf1b protein, human (compound)

1. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
2. L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with ligand perturbagens
4. L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
5. L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens

1. TNFR2 pathways are fully active in cancer regulatory T cells.
2. TNFR2 promotes pancreatic cancer proliferation, migration, and invasion via the NF-κB signaling path…
3. TFNR2 in Ischemia-Reperfusion Injury, Rejection, and Tolerance in Transplantation.
4. Redistribution of TNF Receptor 1 and 2 Expression on Immune Cells in Patients with Bronchial Asthma.
5. Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelia…

There were no clinical trials for tnfrsf1b protein, human